Subscribe
Follow Us
Subscribe
Follow Us

New Study Reveals Breakthrough Triple-Combination Strategy to Strengthen Silver-Based Antimicrobials Against Hospital Infections

Vancouver, British Columbia — April 21, 2026  Andira Pharmaceuticals Inc., in collaboration with researchers at the University of British Columbia, today announced the publication of a new peer-reviewed study describing a novel antimicrobial strategy that dramatically enhances the effectiveness of silver against some of the most dangerous healthcare-associated pathogens, including

Read More

Andira Pharmaceuticals Appoints Jonathan Primer as Lead Commercial Advisor for Revolutionary Infection Control Technology Matrix3™

Vancouver, British Columbia, Canada – Andira Pharmaceuticals is delighted to announce the appointment of Jonathan Primer, a global medical industry expert, as Lead Commercial Advisor. Mr. Primer will play a pivotal role in guiding the company through the commercialization process of its groundbreaking infection control technology, Matrix3™. The need for

Read More

Andira Pharmaceuticals Achieves Remarkable Breast Cancer Tumor Regression with Lead Oncology Candidate XOXO4

SAN FRANCISCO, OCTOBER 2023 –  Andira Pharmaceuticals (“Andira” or the “Company”) is a private pharmaceutical development company dedicated to improving lives and addressing critical illnesses, has announced a significant milestone in the fight against breast cancer. Andira’s Founder and CEO, Dr. Dana Lambert, revealed, “The Company has achieved extraordinary validation

Read More
Load More